TalkMed CEO suspended for eight months
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
PROMINENT cancer specialist Ang Peng Tiam, who is the chief executive officer and main revenue contributor of Catalist-listed TalkMed Group, has been given an eight-month suspension by the Singapore Medical Council after a failed appeal against a misconduct conviction.
Dr Ang contributes over half of the revenue of the firm. He had originally appealed against his S$25,000 fine by the Singapore Medical Council.
TalkMed requested for a trading halt on Wednesday morning. Its shares last traded at S$0.745.
Copyright SPH Media. All rights reserved.
TRENDING NOW
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
Near sell-out launches in March boost developer sales to 1,300 units after four slow months
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Genting Singapore’s Lim Kok Thay receives S$7.5 million pay package for FY2025
